MEDMIRA INC (MIR.CA) Stock Price, Forecast & Analysis
Canada • TSX Venture Exchange • TSX-V:MIR • CA58501R1029
MIR.CA Key Statistics, Chart & Performance
The current stock price of MIR.CA is 0.065 CAD. In the past month the price decreased by -7.14%. In the past year, price decreased by -51.85%.
MIR.CA Technical Analysis
MIR.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MIR.CA. MIR.CA may be in some trouble as it scores bad on both profitability and health.
MIR.CA Financial Highlights
Over the last trailing twelve months MIR.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -5.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -112.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MIR.CA Forecast & Estimates
MIR.CA Ownership
About MIR.CA
Company Profile
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm's tests provide hospitals, labs, clinics and individuals with an instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The firm is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. The company provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
Company Info
MEDMIRA INC
155 Chain Lake Dr.,, Suite 1
Halifax NOVA SCOTIA B3S 1B3 CA
CEO: Hermes Chan
Employees: 52
Phone: 19024501588
MEDMIRA INC / MIR.CA FAQ
What does MIR do?
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm's tests provide hospitals, labs, clinics and individuals with an instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The firm is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. The company provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
Can you provide the latest stock price for MEDMIRA INC?
The current stock price of MIR.CA is 0.065 CAD.
Does MEDMIRA INC pay dividends?
MIR.CA does not pay a dividend.
How is the ChartMill rating for MEDMIRA INC?
MIR.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for MEDMIRA INC?
MEDMIRA INC (MIR.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the number of employees for MEDMIRA INC?
MEDMIRA INC (MIR.CA) currently has 52 employees.
What is the next earnings date for MIR stock?
MEDMIRA INC (MIR.CA) will report earnings on 2026-03-30.